Pituitary gland enlargement on MRI was almost universal in one multi-center review for patients with hypophysitis following CTLA-4 therapy, while this was only seen in a minority of cases (28%) resulting from anti-PD-1 therapy (99). Here, CTLA4 is linked to hypophysitis.